Neola’s CEO to BioStock: “The results from the usability study confirm our product”
Neola Medical’s lung monitoring is user-friendly and safe. These are the results of the usability study cunducted during the spring.
– Successful study results are of great importance as we will use them as part of our upcoming FDA application for market approval in the US, says Neola CEO Hanna Sjöström.
Read the full article at biostock.se:
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se